KeyBanc analyst Brett Fishbin maintains $ICU Medical (ICUI.US)$ with a buy rating, and adjusts the target price from $147 to $198.
According to TipRanks data, the analyst has a success rate of 94.1% and a total average return of 22.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $ICU Medical (ICUI.US)$'s main analysts recently are as follows:
The firm is encouraged by considerable advancements made thus far in the year, showcasing enhanced operational stability. With guidance remaining on the conservative side, there is a belief in the potential for sustained outperformance moving into the latter half of 2024. Additionally, there are several factors that could drive further upside in 2025.
ICU Medical is recognized for its robust usage environment and a commanding presence in the expanding market for IVs and disposables. Despite these strengths, analysis and industry feedback indicate that the company is not expected to capture significant market share from its main competitors, which results in projections that align with the general consensus.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
